Distensibility of the ductus arteriosus in neonates and young infants undergoing transcatheter closure.


Journal

Heart and vessels
ISSN: 1615-2573
Titre abrégé: Heart Vessels
Pays: Japan
ID NLM: 8511258

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 23 05 2021
accepted: 13 08 2021
pubmed: 19 8 2021
medline: 7 4 2022
entrez: 18 8 2021
Statut: ppublish

Résumé

Device migration is one of serious complications in neonates and infants undergoing transcatheter closure of the patent ductus arteriosus (PDA). We hypothesize that neonates and young infants possess the distensibility of the ductus, which may be related to device migration. We retrospectively reviewed angiographic findings in 41 neonates and infants who underwent transcatheter closure of PDA. We measured diameters of the ductus at the pulmonary (PA) side, the center, and the aortic (AO) side before PDA closure, and the device center diameter after device closure. The distensibility index was defined as the ratio of the device center diameter after device deployment to the diameter at the center of the ductus before PDA closure. Age and weight at the procedure were 168 (117-260) days and 5.3 (4.3-6.9) kg, respectively. Thirty-seven subjects accomplished the successful device closure, and four subjects were declined because of the device instability or migration. Implanted devices included Amplatzer Duct Occluders in 33 subjects and Amplatzer Vascular Plug-2 in 8 subjects. The PDA diameters at PA side, at the center, AO side, and the device center diameter were 3.2 (2.2-4.3) mm, 4.7 (3.6-5.7) mm, 7.7 (6.3-9.4) mm, and 5.8 (4.2-6.9) mm, respectively. The PDA diameter before closure was not correlated age and weight. The distensibility index was 1.28 (1.06-1.64), which was significantly correlated to age (r = - 0.49, P = 0.001) and weight (r = - 0.53, P < 0.001). Infants with the younger age and the lower weight have the more distensible PDA, which may be a risk for device migration.

Identifiants

pubmed: 34406441
doi: 10.1007/s00380-021-01925-9
pii: 10.1007/s00380-021-01925-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

513-516

Informations de copyright

© 2021. Springer Japan KK, part of Springer Nature.

Références

O’Byrne ML, Millenson ME, Grady CB, Huang J, Bamat NA, Munson DA, Song L, Dori Y, Gillespie MJ, Rome JJ, Glatz AC (2019) Trends in transcatheter and operative closure of patent ductus arteriosus in neonatal intensive care units: analysis of data from the Pediatric Health Information Systems Database. Am Heart J 217:121–130
doi: 10.1016/j.ahj.2019.08.009
Baruteau AE, Hascoët S, Baruteau J, Boudjemline Y, Lambert V, Angel CY, Belli E, Petit J, Pass R (2014) Transcatheter closure of patent ductus arteriosus: past, present and future. Arch Cardiovasc Dis 107:122–132
doi: 10.1016/j.acvd.2014.01.008
Backes CH, Kennedy KF, Locke M, Cua CL, Ball MK, Fick TA, Rivera BK, Smith CV, Holzer RJ, Boe BA, Berman DP, Bergersen L, Armstrong AK (2017) Transcatheter occlusion of the patent ductus arteriosus in 747 infants <6 kg. JACC Cardiovasc Interv 10:1729–1737
doi: 10.1016/j.jcin.2017.05.018
Mullins CE (2006) Transcatheter occlusion of the patent ductus arteriosus (PDA). In: Mullins CE (ed) Cardiac catherization in congenital heart disease: pediatric and adult. Blackwell Futura, Massachusetts, pp 693–727
Smith GC (1998) The pharmacology of the ductus arteriosus. Pharmacol Rev 50:35–58
pubmed: 9549757
Yokoyama U, Minamisawa S, Ishikawa Y (2010) Regulation of vascular tone and remodeling of the ductus arteriosus. J Smooth Muscle Res 46:77–87
doi: 10.1540/jsmr.46.77
Gittenberger-de Groot AC (1977) Persistent ductus arteriosus: most probably a primary congenital malformation. Br Heart J 39:610–618
doi: 10.1136/hrt.39.6.610
Chuaqui B, Piwonka G, Farrú O (1977) Uber den Wandbau des persistierenden Ductus arteriosus [The wall in persistent ductus arteriosus (author’s transl)]. Virchows Arch A Pathol Anat Histol 372:315–324
doi: 10.1007/BF00432406

Auteurs

Kota Nagasawa (K)

Department of Pediatrics, Kyushu Hospital, Japan Community Healthcare Organization, 1-8-1, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka, 806-8501, Japan.

Jun Muneuchi (J)

Department of Pediatrics, Kyushu Hospital, Japan Community Healthcare Organization, 1-8-1, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka, 806-8501, Japan. jmune@msn.com.

Yuichiro Sugitani (Y)

Department of Pediatrics, Kyushu Hospital, Japan Community Healthcare Organization, 1-8-1, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka, 806-8501, Japan.

Hiroki Ezaki (H)

Department of Pediatrics, Kyushu Hospital, Japan Community Healthcare Organization, 1-8-1, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka, 806-8501, Japan.

Hirohito Doi (H)

Department of Pediatrics, Kyushu Hospital, Japan Community Healthcare Organization, 1-8-1, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka, 806-8501, Japan.

Takashi Furuta (T)

Department of Pediatrics, Kyushu Hospital, Japan Community Healthcare Organization, 1-8-1, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka, 806-8501, Japan.

Masaru Kobayashi (M)

Department of Pediatrics, Kyushu Hospital, Japan Community Healthcare Organization, 1-8-1, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka, 806-8501, Japan.

Mamie Watanabe (M)

Department of Pediatrics, Kyushu Hospital, Japan Community Healthcare Organization, 1-8-1, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka, 806-8501, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH